
By Ahmed Aboulenein
WASHINGTON, Dec 23 (Reuters) - Enrollment for health insurance under the U.S. Affordable Care Act dipped to 15.6 million for 2026, Mehmet Oz, the U.S. Centers for Medicare and Medicaid Services administrator, said on Tuesday, from roughly 16 million last year.
The drop comes as federal subsidies, expanded during the pandemic, are set to expire on December 31, leading to sharp premium increases in 2026. Monthly premiums for subsidized ACA plans, also known as Obamacare after the former president, are projected to more than double, rising to an average of $1,904 annually from $888 in 2025.
In a social media post, Oz attributed the enrollment decline to CMS actions targeting fraudulent and improper sign-ups. The post was not accompanied by fresh agency data. The most recent CMS report, published this month, shows 19.9% of enrollees renewing coverage — down slightly from 20.5% this time last year.
A recent poll by health policy nonprofit KFF highlighted the potential fallout from the subsidy expiration, with 25% of enrollees indicating they would forgo health insurance in 2026 if their premiums doubled as expected.
Congress did not renew the enhanced subsidies enacted during the pandemic, leaving approximately 24 million Americans at risk of steep cost increases starting in January.
Enrollment for ACA plans opened in November and runs until January 15. Historically, sign-ups have spiked in early January and have grown year-on-year over the past several years, doubling from about 12 million in 2021 due to the expanded subsidies. Insurers and state health officials expect a drop in 2026 enrollment.
President Donald Trump and Republican lawmakers have been divided for months on a replacement for the subsidies. Republicans have been promising an ACA alternative for over a decade, but have yet to produce one with a passable consensus that retains Obamacare's consumer protections.
(Reporting by Ahmed AbouleneinEditing by Rod Nickel)
latest_posts
- 1
‘Inoculation’ helps people spot political deepfakes, study finds - 2
EU-funded BioSupPack project turns brewery waste into bioplastics - 3
Senegal president signs tough new anti-LGBT law doubling jail terms - 4
Kobe Bryant called this WNBA star the 'Gold Mamba.' She turned his advice to her into a tattoo. - 5
Getting Your Youngsters' Future: Grasping Legacy Regulations
‘Serving is not just a place’: Bayside Church Granite Bay reimagines annual mission amid conflict in Mexico
Artemis 2 astronauts — now halfway to the moon — report 'burning smell' from toilet, but everything's fine
37 Things Just Individuals Experiencing childhood during the 80s Will Comprehend
Pick Your #1 Kind Of Bread
Smooth countdown continues for Artemis II moon mission
Heading to Florida for NASA's Artemis 2 moon launch? Here's what to know before you go
IDF begins destroying homes used by Hezbollah as forces move deeper into southern Lebanon
Figure out How to Modify Your Pre-assembled Home for Greatest Solace and Stylish Allure
Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas













